5-aminosalicylates are not associated with adverse outcomes in Inflammatory Bowel Disease patients with COVID-19: Analysis from an international registry

Ungaro, R.; Brenner, E.; Agrawal, M.; Gearry, R. B.; Kaplan, G. O.; Kissous-Hunt, M.; Ng, S. C.; Rahier, J. F.; Reinisch, W.; Steinwurz, F.; Zhang, X.; Lewis, J. D.; Kappelman, M. D.; Colombel, J. F.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

5-aminosalicylates are not associated with adverse outcomes in Inflammatory Bowel Disease patients with COVID-19: Analysis from an international registry

Ungaro, R.; Brenner, E.; Agrawal, M.; Gearry, R. B.; Kaplan, G. O.; Kissous-Hunt, M.; Ng, S. C.; Rahier, J. F.; Reinisch, W.; Steinwurz, F.; Zhang, X.; Lewis, J. D.; Kappelman, M. D.; Colombel, J. F..

Journal of Crohns & Colitis ; 15:S006-S007, 2021.

Article in English | Web of Science | ID: covidwho-1510911

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Web of Science Language: English Journal: Journal of Crohns & Colitis Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Web of Science Language: English Journal: Journal of Crohns & Colitis Year: 2021 Document Type: Article